BAILARD, INC. - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 43 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,375
-81.6%
11,899
-75.1%
0.00%
-100.0%
Q2 2023$67,257
+112.6%
47,700
+139.7%
0.00%
+100.0%
Q1 2023$31,641
-92.1%
19,900
-60.2%
0.00%
-92.9%
Q3 2021$401,000
-75.6%
50,000
-65.5%
0.01%
-75.4%
Q2 2021$1,644,000
+380.7%
145,000
+291.9%
0.06%
+338.5%
Q1 2021$342,00037,0000.01%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$421,3140.28%
BVF INC/IL 3,614,662$5,277,4070.22%
Samsara BioCapital, LLC 689,709$1,006,9750.22%
Rubric Capital Management LP 1,330,983$1,943,2350.08%
HAMILTON LANE ADVISORS LLC 35,791$520.02%
MAI Capital Management 426,916$623,2970.01%
Jasper Ridge Partners, L.P. 92,939$135,6910.01%
BOURGEON CAPITAL MANAGEMENT LLC 17,500$25,5500.01%
RP Management, LLC 3,700$5,4020.01%
Laurion Capital Management LP 698,000$1,019,0800.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders